Israel’s PhaseV develops causal machine learning (ML) technology that optimizes clinical trial design and analysis. Its goal is to prevent bio-techs wasting money on failed or badly designed trials of new treatments.  It boosts clinical trial success rates while maximizing resource and time efficiency.

https://www.calcalistech.com/ctechnews/article/skymnbhf6

https://phasevtrials.com/